CFTC Challenges CME’s Case Against Bitcoin Perpetuals

The CFTC says CME Group has not shown concrete or imminent harm from the approval of Kalshi’s Bitcoin perpetual futures contract and is asking a federal court to dismiss CME’s challenge for lack of standing. CME is seeking to overturn the May 29, 2026 approval, arguing that contracts without an expiry date should be regulated as swaps, not futures, under the Commodity Exchange Act. The CFTC disputes CME’s competition claims, citing CME’s statements that customer demand for perpetuals was limited and that its own crypto-futures volume grew more than sevenfold in three years. CME counters that regulated US Bitcoin perpetual futures could compete with its dated contracts. It also says Kalshi self-certified more than a dozen additional crypto perpetuals, with trading across the products exceeding $1 billion by the time CME filed suit. The CFTC’s approval applies to a specific contract, not all perpetual futures. The court’s decision could affect US oversight and availability of crypto derivatives. As trading in the products grows, reversing their market development could become more difficult, but the case’s immediate effect on Bitcoin’s price is uncertain.